Osimertinib is associated with reversible and dose-independent cancer therapy-related cardiac dysfunctionKei Kunimasa, Toru Kumagai, Toru Oka et al.|Lung Cancer|2020Cited by 43
Elective Nodal Irradiation for Non-small Cell Lung Cancer Complicated With Chronic Obstructive Pulmonary Disease Affects Immunotherapy Αfter Definitive ChemoradiotherapyMasahiro Morimoto, Teruki Teshima, Kazumi Nishino et al.|Anticancer Research|2020Cited by 9
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer CohortMakoto Nishio, Koichi Azuma, Daichi Fujimoto et al.|Cancer Research Communications|2024Cited by 4